uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.
Quick Stats
Jan 30, 202652.7
AI Score
HOLD0.82
Volume Ratio
Feb 26, 2026
Next Earnings
15
+ve Days (30d)
15
-ve Days (30d)
QURE Stock Summary
Last updated Jan 30, 2026
QURE is currently trading at $22.72, positioned below its 200-day moving average of $24.19, suggesting bearish momentum. The stock has a 52-week range of $7.76 to $71.5.
Technical Analysis: The 50-day moving average stands at $23.94, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 44.651, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.206, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates QURE at 52.7/100 with a HOLD recommendation.
QURE (uniQure N.V.) Indicators
Last updated Jan 30, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 44.651 |
| CMF (20) | -0.206 |
| ROC (10) | 3.367 |
| ADX (14) | 17.316 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.524 |
| AROONOSC (14) | -21.429 |
| WILLAMS %R (14) | -66.237 |
| MFI (14) | 44.279 |
QURE Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
QURE Price vs Max Options Open Interest
QURE Max Change In Options Open Interest
QURE Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
QURE Daily Out of Money Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
QURE Daily In the Money Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
QURE Most Active Options by Volume(near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
uniQure N.V. is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
QURE Moving Averages Analysis
QURE (uniQure N.V.) Simple Moving Averages
Moving Averages are last updated Jan 30, 2026
| Days | MA |
|---|---|
| 10 | 23.35 |
| 20 | 23.11 |
| 30 | 23.48 |
| 50 | 23.94 |
| 100 | 33.74 |
| 200 | 24.19 |
QURE Fundamental Analysis
| P/E (Forward) | 27.933 |
| P/E (Trailing) | -- |
| Market Cap ($) | 1.4 billion |
| Earnings/Share ($) | -4.4 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -3.3343 |
| EPS Estimate Next Year ($) | -2.7755 |
| WallStreet Target Price ($) | 53.5059 |
| Most Recent Quarter |
News: Investors are skeptical about the future of $QURE as they believe the stock is overvalued and insiders are not buying. They predict a nosedive in the near future. Meanwhile, $BOXL is expected to experience a big squeeze due to its low market cap and recent fundraising.
Updated 2025-09-25 18:00:02